Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,603,969
+$56,200,356 QoQ
Shares Held
4,180,500
+7326.5% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#10
of 625 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Mar 31, 2024CallValue
$5,640,000
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Man Group plc holds $1,927,079,072 across 11 Drug Manufacturers - General names. OGN ranks #9 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
398,861 | $478,405,888 | |
| 2 | ABBV |
AbbVie Inc.
|
1,704,016 | $428,798,585 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,682,000 | $269,776,838 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,235,196 | $156,054,661 | |
| 5 | JNJ |
Johnson & Johnson
|
517,830 | $131,513,284 | |
| 6 | AZN |
Astrazeneca PLC
|
683,112 | $129,531,696 | |
| 7 | MRK |
Merck & Co., Inc.
|
990,469 | $127,275,266 | |
| 8 | AMGN |
Amgen Inc
|
234,023 | $84,744,407 |
All Filings in OGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,603,969 | 4,180,500 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $403,613 | 56,292 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $321,863 | 30,137 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $660,350 | 68,218 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $1,369,536 | 91,792 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,514,389 | 131,437 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,415,772 | 116,704 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,640,000 | 300,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $608,668 | 32,376 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,326,000 | 300,000 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $434,790 | 30,152 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $960,893 | 55,351 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $8,380,665 | 402,723 | Shares | Defined | 2023-08-14 | |
| 2022-03-31 | $2,878,790 | 82,416 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,087,430 | 35,712 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $827,717 | 25,243 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $448,542 | 14,823 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||